Hinz V - Search Results

1

Who chooses, who uses, who rates: the impact of agency on electronic word-of-mouth about hospitals stays.

Drevs F, Hinz V. Drevs F, et al. Among authors: hinz v. Health Care Manage Rev. 2014 Jul-Sep;39(3):223-33. doi: 10.1097/HMR.0b013e3182993b6a. Health Care Manage Rev. 2014. PMID: 23727786

2

Cooperation for a competitive position: The impact of hospital cooperation behavior on organizational performance.

Büchner VA, Hinz V, Schreyögg J. Büchner VA, et al. Among authors: hinz v. Health Care Manage Rev. 2015 Jul-Sep;40(3):214-24. doi: 10.1097/HMR.0000000000000027. Health Care Manage Rev. 2015. PMID: 25054238

3

Health systems: changes in hospital efficiency and profitability.

Büchner VA, Hinz V, Schreyögg J. Büchner VA, et al. Among authors: hinz v. Health Care Manag Sci. 2016 Jun;19(2):130-43. doi: 10.1007/s10729-014-9303-1. Epub 2014 Oct 11. Health Care Manag Sci. 2016. PMID: 25304876

4

Extending Miles & Snow's strategy choice typology to the German hospital sector.

Helmig B, Hinz V, Ingerfurth S. Helmig B, et al. Among authors: hinz v. Health Policy. 2014 Dec;118(3):363-76. doi: 10.1016/j.healthpol.2014.06.006. Epub 2014 Jul 5. Health Policy. 2014. PMID: 25047455

5

RNAM EXPRESSION AND DNA METHYLATION OF DKK2 GENE IN COLORECTAL CÂNCER.

Mamelli RE, Felipe AV, Silva TD, Hinz V, Forones NM. Mamelli RE, et al. Among authors: hinz v. Arq Gastroenterol. 2021 Jan-Mar;58(1):55-60. doi: 10.1590/S0004-2803.202100000-10. Arq Gastroenterol. 2021. PMID: 33909798 Free article.

6

IKCa-channel blockers. Part 2: discovery of cyclohexadienes.

Urbahns K, Goldmann S, Krüger J, Horváth E, Schuhmacher J, Grosser R, Hinz V, Mauler F. Urbahns K, et al. Among authors: hinz v. Bioorg Med Chem Lett. 2005 Jan 17;15(2):401-4. doi: 10.1016/j.bmcl.2004.10.063. Bioorg Med Chem Lett. 2005. PMID: 15603962

7

Expression, purification, biochemical and pharmacological characterization of a recombinant aprotinin variant.

Apeler H, Peters J, Schröder W, Schneider KH, Lemm G, Hinz V, Rossouw GJ, Dembowsky K. Apeler H, et al. Among authors: hinz v. Arzneimittelforschung. 2004;54(8):483-97. doi: 10.1055/s-0031-1297003. Arzneimittelforschung. 2004. PMID: 15460216

8

Selective intermediate-/small-conductance calcium-activated potassium channel (KCNN4) blockers are potent and effective therapeutics in experimental brain oedema and traumatic brain injury caused by acute subdural haematoma.

Mauler F, Hinz V, Horváth E, Schuhmacher J, Hofmann HA, Wirtz S, Hahn MG, Urbahns K. Mauler F, et al. Among authors: hinz v. Eur J Neurosci. 2004 Oct;20(7):1761-8. doi: 10.1111/j.1460-9568.2004.03615.x. Eur J Neurosci. 2004. PMID: 15379997

9

Neuroprotective and brain edema-reducing efficacy of the novel cannabinoid receptor agonist BAY 38-7271.

Mauler F, Hinz V, Augstein KH, Fassbender M, Horváth E. Mauler F, et al. Among authors: hinz v. Brain Res. 2003 Oct 31;989(1):99-111. doi: 10.1016/s0006-8993(03)03376-6. Brain Res. 2003. PMID: 14519516

10

Different cumulative pregnancy rates in patients with repeated IVF- or ICSI cycles: possible influence of a male factor.

Stalf T, Herrero J, Turley H, Hinz V, Müller B, Blank T, Henkel R, Schill WB, Gips H. Stalf T, et al. Among authors: hinz v. Andrologia. 1999 May;31(3):149-56. Andrologia. 1999. PMID: 10363119

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page